The San Francisco company cut 500 jobs earlier this year after a cancer drug failed late-stage clinical trials, leading to the dissolution of a partnership with Bristol-Myers Squibb Co.
The San Francisco company cut 500 jobs earlier this year after a cancer drug failed late-stage clinical trials, leading to the dissolution of a partnership with Bristol-Myers Squibb Co.
